Quantitative proteomic analysis reveals protein expression changes in the murine neuronal secretome during apoptosis

Journal of Proteomics

Volumn 77, Issue , 2012, Pages 394-405

  Thouvenot, Eric ^a,b   Urbach, Serge ^a   Vigy, Oana ^a   Séveno, Martial ^c   Galéotti, Nathalie ^a   Nguyen, Geneviève ^d   Bockaert, Joël ^a   Marin, Philippe ^a  

^a INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

^b DEPARTMENT OF NEUROLOGY   (France)

^c CNRS UMS2432   (France)

^d l'alimentation et l'Environnement   (France)

Author keywords

Apoptosis; Biomarker; Neuron; Secretome; SILAC

Indexed keywords

ACCURACY; AMINO ACID SEQUENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL GRANULE; CELL SURVIVAL; CEREBELLUM; CEREBROSPINAL FLUID; ISOTOPE LABELING; LIQUID CHROMATOGRAPHY; MOUSE; NERVE CELL; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEOMICS; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY;

ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CELL SURVIVAL; CELLS, CULTURED; CEREBELLUM; HUMANS; ISOTOPE LABELING; MICE; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; NEURONS; PROTEOME;

MURINAE;

EID: 84870389493     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.09.013     Document Type: Article

References (42)

1. Zougman A., Pilch B., Podtelejnikov A., Kiehntopf M., Schnabel C., Kumar C., et al. Integrated analysis of the cerebrospinal fluid peptidome and proteome. J Proteome Res 2008, 7:386-399.
2. Mouton-Barbosa E., Roux-Dalvai F., Bouyssie D., Berger F., Schmidt E., Righetti P.G., et al. In-depth exploration of cerebrospinal fluid by combining peptide ligand library treatment and label-free protein quantification. Mol Cell Proteomics 2010, 9:1006-1021.
3. Schutzer S.E., Liu T., Natelson B.H., Angel T.E., Schepmoes A.A., Purvine S.O., et al. Establishing the proteome of normal human cerebrospinal fluid. PLoS One 2010, 5:e10980.
4. Thouvenot E., Urbach S., Dantec C., Poncet J., Seveno M., Demettre E., et al. Enhanced detection of CNS cell secretome in plasma protein-depleted cerebrospinal fluid. J Proteome Res 2008, 7:4409-4421.
5. Pan S., Zhu D., Quinn J.F., Peskind E.R., Montine T.J., Lin B., et al. A combined dataset of human cerebrospinal fluid proteins identified by multi-dimensional chromatography and tandem mass spectrometry. Proteomics 2007, 7:469-473.
6. Kroksveen A.C., Opsahl J.A., Aye T.T., Ulvik R.J., Berven F.S. Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics. J Proteomics 2011, 74:371-388.
7. Hsich G., Kenney K., Gibbs C.J., Lee K.H., Harrington M.G. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 1996, 335:924-930.
8. Ekshyyan O., Aw T.Y. Apoptosis: a key in neurodegenerative disorders. Curr Neurovasc Res 2004, 1:355-371.
9. Gallo V., Kingsbury A., Balazs R., Jorgensen O.S. The role of depolarization in the survival and differentiation of cerebellar granule cells in culture. J Neurosci 1987, 7:2203-2213.
10. D'Mello S.R., Galli C., Ciotti T., Calissano P. Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. Proc Natl Acad Sci U S A 1993, 90:10989-10993.
11. Desagher S., Severac D., Lipkin A., Bernis C., Ritchie W., Le Digarcher A., et al. Genes regulated in neurons undergoing transcription-dependent apoptosis belong to signaling pathways rather than the apoptotic machinery. J Biol Chem 2005, 280:5693-5702.
12. Liao L., Park S.K., Xu T., Vanderklish P., Yates J.R. Quantitative proteomic analysis of primary neurons reveals diverse changes in synaptic protein content in fmr1 knockout mice. Proc Natl Acad Sci U S A 2008, 105:15281-15286.
13. Spellman D.S., Deinhardt K., Darie C.C., Chao M.V., Neubert T.A. Stable isotopic labeling by amino acids in cultured primary neurons: application to brain-derived neurotrophic factor-dependent phosphotyrosine-associated signaling. Mol Cell Proteomics 2008, 7:1067-1076.
14. Zhang G., Deinhardt K., Chao M.V., Neubert T.A. Study of neurotrophin-3 signaling in primary cultured neurons using multiplex stable isotope labeling with amino acids in cell culture. J Proteome Res 2011, 10:2546-2554.
15. Cox J., Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 2008, 26:1367-1372.
16. Team RDC R: a language and environment for statistical computing 2009, R Foundation for Statistical Computing, Vienna, Austria.
17. Maere S., Heymans K., Kuiper M. BiNGO: a cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 2005, 21:3448-3449.
18. Bhatia V.N., Perlman D.H., Costello C.E., McComb M.E. Software tool for researching annotations of proteins: open-source protein annotation software with data visualization. Anal Chem 2009, 81:9819-9823.
19. Yu L.R., Conrads T.P., Uo T., Kinoshita Y., Morrison R.S., Lucas D.A., et al. Global analysis of the cortical neuron proteome. Mol Cell Proteomics 2004, 3:896-907.
20. Cousin C., Bracquart D., Contrepas A., Corvol P., Muller L., Nguyen G. Soluble form of the (pro)renin receptor generated by intracellular cleavage by furin is secreted in plasma. Hypertension 2009, 53:1077-1082.
21. Lafon-Cazal M., Perez V., Bockaert J., Marin P. Akt mediates the anti-apoptotic effect of NMDA but not that induced by potassium depolarization in cultured cerebellar granule cells. Eur J Neurosci 2002, 16:575-583.
22. Nguyen G., Delarue F., Burckle C., Bouzhir L., Giller T., Sraer J.D. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 2002, 109:1417-1427.
23. Mattson M.P., Cheng B., Culwell A.R., Esch F.S., Lieberburg I., Rydel R.E. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein. Neuron 1993, 10:243-254.
24. Gauthier S., Kaur G., Mi W., Tizon B., Levy E. Protective mechanisms by cystatin C in neurodegenerative diseases. Front Biosci (Schol Ed) 2011, 3:541-554.
25. Valenzuela R., Barroso-Chinea P., Villar-Cheda B., Joglar B., Munoz A., Lanciego J.L., et al. Location of prorenin receptors in primate substantia nigra: effects on dopaminergic cell death. J Neuropathol Exp Neurol 2010, 69:1130-1142.
26. Kuhn P.H., Koroniak K., Hogl S., Colombo A., Zeitschel U., Willem M., et al. Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons. EMBO J 2012, 31:3157-3168.
27. Zhou L., Barao S., Laga M., Bockstael K., Borgers M., Gijsen H., et al. The neural cell adhesion molecules L1 and CHL1 are cleaved by BACE1 protease in vivo. J Biol Chem 2012, 287:25927-25940.
28. Contestabile A. Cerebellar granule cells as a model to study mechanisms of neuronal apoptosis or survival in vivo and in vitro. Cerebellum 2002, 1:41-55.
29. Chin P.C., Majdzadeh N., D'Mello S.R. Inhibition of GSK3beta is a common event in neuroprotection by different survival factors. Brain Res Mol Brain Res 2005, 137:193-201.
30. Miller T.M., Tansey M.G., Johnson E.M., Creedon D.J. Inhibition of phosphatidylinositol 3-kinase activity blocks depolarization- and insulin-like growth factor I-mediated survival of cerebellar granule cells. J Biol Chem 1997, 272:9847-9853.
31. D'Mello S.R., Borodezt K., Soltoff S.P. Insulin-like growth factor and potassium depolarization maintain neuronal survival by distinct pathways: possible involvement of PI 3-kinase in IGF-1 signaling. J Neurosci 1997, 17:1548-1560.
32. Zhong J., Deng J., Huang S., Yang X., Lee W.H. High K+ and IGF-1 protect cerebellar granule neurons via distinct signaling pathways. J Neurosci Res 2004, 75:794-806.
33. Urakubo T., Tominaga-Yoshino K., Ogura A. Non-synaptic exocytosis enhanced in rat cerebellar granule neurons cultured under survival-promoting conditions. Neurosci Res 2003, 45:429-436.
34. Calegari F., Coco S., Taverna E., Bassetti M., Verderio C., Corradi N., et al. A regulated secretory pathway in cultured hippocampal astrocytes. J Biol Chem 1999, 274:22539-22547.
35. Ohkubo N., Vitek M.P., Morishima A., Suzuki Y., Miki T., Maeda N., et al. Reelin signals survival through Src-family kinases that inactivate BAD activity. J Neurochem 2007, 103:820-830.
36. Katsuno M., Adachi H., Banno H., Suzuki K., Tanaka F., Sobue G. Transforming growth factor-beta signaling in motor neuron diseases. Curr Mol Med 2011, 11:48-56.
37. Elvers M., Pfeiffer J., Kaltschmidt C., Kaltschmidt B. TGF-beta2 neutralization inhibits proliferation and activates apoptosis of cerebellar granule cell precursors in the developing cerebellum. Mech Dev 2005, 122:587-602.
38. Polazzi E., Altamira L.E., Eleuteri S., Barbaro R., Casadio C., Contestabile A., et al. Neuroprotection of microglial conditioned medium on 6-hydroxydopamine-induced neuronal death: role of transforming growth factor beta-2. J Neurochem 2009, 110:545-556.
39. Ludwig A., Blume J., Diep T.M., Yuan J., Mateos J.M., Leuthauser K., et al. Calsyntenins mediate TGN exit of APP in a kinesin-1-dependent manner. Traffic 2009, 10:572-589.
40. Tizon B., Ribe E.M., Mi W., Troy C.M., Levy E. Cystatin C protects neuronal cells from amyloid-beta-induced toxicity. J Alzheimers Dis 2010, 19:885-894.
41. Hua Y.Q., Ouyang H.Q., Chen Z., Meng Z.Q., Luo J.M., Lin J.H., et al. Promoted cancer growth by stimulating cell proliferation and decreasing apoptosis using a lentivirus-based EphB2 RNAi in pancreatic carcinoma CFPAC-1 cells. Biomed Pharmacother 2011, 65:123-131.
42. Perrin R.J., Craig-Schapiro R., Malone J.P., Shah A.R., Gilmore P., Davis A.E., et al. Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease. PLoS One 2011, 6:e16032.